Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry

Aquatic Toxicology

Volumn 93, Issue 4, 2009, Pages 217-224

  Owen, Stewart F ^a,c   Huggett, Duane B ^b   Hutchinson, Thomas H ^c   Hetheridge, Malcolm J ^c   Kinter, Lewis B ^c   Ericson, Jon F ^b   Sumpter, John P ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b PFIZER INC   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Environmental risk assessment (ERA); Pharmaceuticals in the environment (PIE); Propranolol; Rainbow trout

Indexed keywords

PROPRANOLOL;

BIOLOGICAL UPTAKE; BIOMETRY; DRUG; ENVIRONMENTAL RISK; FISH; GROWTH RATE; PLASMA; RISK ASSESSMENT;

ANIMAL TISSUE; AQUATIC ENVIRONMENT; ARTICLE; BIOMETRY; BODY WEIGHT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; FEMALE; GROWTH RATE; HEART SIZE; LIVER SIZE; NONHUMAN; PRIORITY JOURNAL; RAINBOW TROUT; RISK ASSESSMENT; SAFETY; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BIOMETRY; BODY COMPOSITION; BODY WEIGHT; FRESH WATER; HEART; LIVER; ONCORHYNCHUS MYKISS; ORGAN SIZE; PROPRANOLOL; WATER POLLUTANTS, CHEMICAL;

AMPHIBIA; MAMMALIA; ONCORHYNCHUS MYKISS; SALMONIDAE; VERTEBRATA;

EID: 67649743400     PISSN: 0166445X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aquatox.2009.05.009     Document Type: Article

References (44)

1. Ankley G.T., Brooks B.W., Huggett D.B., and Sumpter J.P. Repeating history: pharmaceuticals in the environment. Environ. Sci. Technol. 41 (2007) 8211-8217
2. Ashton D., Hilton M., and Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 333 (2004) 167-184
3. Bolger T., and Connolly P.L. The selection of suitable indices for the measurement and analysis of fish condition. J. Fish Biol. 34 (1989) 171-182
4. 2-sensitive chemoreceptor activity in trout gills. Am. J. Physiol. 258 (1990) R1089-1091
5. Chidsey C.A., Morselli P., Bianchetti G., Morganti A., Leonetti G., and Zanchetti. Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation 52 (1975) 313-318
6. Delistraty D., Taylor B., and Anderson R. Comparisons of acute toxicity of selected chemicals to rainbow trout and rats. Ecotoxicol. Environ. Saf. 39 (1998) 195-200
7. ENDS. Report, E. Chasing environmental risk assessment for pharmaceuticals. ENDS report 365 (2005) 29-32
8. Escher B.I., Bramaz N., Eggen R.I.L., and Richter M. In vitro assessment of modes of toxic action of pharmaceuticals in aquatic life. Environ. Sci. Technol. 39 (2005) 3090-3100
9. Ferrari B., Mons R., Vollat B., Fraysse B., Paxeus N., Lo Giudice R., Pollio A., and Garric J. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 23 (2004) 1344-1354
10. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 76 (2006) 122-159
11. Fitzsimmons P.N., Fernandez J.D., Hoffman A.D., Butterworth B.C., and Nichols J.W. Branchial elimination of superhyrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 55 (2001) 23-34
12. Gamperl A.K., Wilkinson M., and Boutilier R.G. β-Adrenoreceptors in the trout (Oncorhynchus mykiss) heart: characterisation, quantification and effects of repeated catecholamine exposure. Gen. Comp. Endocrinol. 95 (1994) 227-259
13. Gunnarsson L., Jauhianen A., Kristiansson E., Nerman O., and Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 42 (2008) 5807-5813
14. Hannah, R., D'Aco V.J., Anderson, P.D., Buzby, M.E., Caldwell, D.J., Cunningham, V.L., Ericson, J.F., Johnson, A.C., Parke, N.J., Samuelian, J.H., Sumpter, J.P. Exposure assessment of 17α-ethinyl estradiol in surface waters of the U.S. and Europe. Environ. Toxicol. Chem., in press.
15. Hilton M.J., and Thomas K.V. Determination of selected human pharmaceutical compounds in effluent and surface water samples by high-performance liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A 1015 (2003) 129-141
16. Hollander M., and Wolfe D.A. Non-parametric Statistics (1973), J. Wiley and Sons. 0-471-40635-X 120-121
17. Huggett D.B., Brooks B.W., Peterson B., Foran C.M., and Schlenk D. Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic animals. Arch. Environ. Contam. Toxicol. 43 (2002) 229-235
18. Huggett D.B., Khan I.A., Foran C.M., and Schlenk D. Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ. Pollut. 121 (2003) 199-205
19. Huggett D.B., Ericson J.F., Cook J.C., and Williams R.T. Plasma concentrations of human pharmaceuticals as predictors of pharmacological responses in fish. In: Kummerer (Ed). Pharmaceuticals in the Environment: Sources, Fate, effects and Risks. 2nd ed. (2004), Springer-Verlag, Berlin (Chapter 27)
20. Kariv I., Cao H., and Oldenburg K.R. Development of a high throughput equilibrium dialysis method. J. Pharmacol. Sci. 90 5 (2001) 580-587
21. Keen J.E., Vianzon D.-M., Farrell A.P., and Tibbits G.F. Thermal acclimation alters both adrenergic sensitivity and adrenoreceptor density in cardiac tissue of rainbow trout. J. Exp. Biol. 181 (1993) 27-47
22. Länge R., and Dietrich D. Environmental risk assessment of pharmaceutical drug substances - conceptual considerations. Toxicol. Lett. 131 (2002) 97-104
23. Larsson D.G.J., Fredriksson S., Sandblom E., Paxeus N., and Axelsson M. Is heart rate in fish a sensitive indicator to evaluate acute effects of β-blockers in surface water?. Environ. Toxicol. Pharmacol. 22 (2006) 338-340
24. Larsson D.G.J., de Pedro C., and Paxeus N. Effluent from drug manufacturers contains extremely high levels of pharmaceuticals. J. Hazard. Mat. 148 (2007) 751-755
25. Lortie M.B., and Moon T.W. The rainbow trout skeletal muscle β-adrenergic system: characterization and signalling. Am. J. Physiol. 284 (2003) R689-697
26. McKinley S.J., and Hazel J.R. Does membrane fluidity contribute to thermal compensation of β-adrenergic signal transduction in isolated trout hepatocytes?. J. Exp. Biol. 203 (2000) 631-640
27. Nichols J.W., McKim J.M., Lein G.J., Hoffman A.D., and Bartelson S.L. Physiologically based toxicokinetic modelling of three waterborne chloroethanes in rainbow trout (Oncorhynchus mykiss). Toxicol. Appl. Pharmacol. 110 (1991) 374-389
28. 2-adrenoreceptor from the rainbow trout. Eur. J. Biochem. 268 (2001) 6465-6472
29. 3-AR subtype. Am. J. Physiol. 285 (2003) R526-535
30. OECD, 2000. OECD guideline for the testing of chemicals: 215 Fish, juvenile growth test. Organisation for Economic Co-operation and Development (Original Guideline, adopted 21st January 2000), http://www.oecd.org/document/62/0,2340,en_2649_34377_2348862_1_1_1_1,00. html.
31. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J.-A., Winter M.J., and Sumpter J.P. Comparative physiology, pharmacology and toxicology of β-blockers in fish: a critical review. Aquat. Toxicol. 8 (2007) 145-162
32. Packard G.C., and Boardman T.J. The use of percentages and size specific indices to normalize physiological data for variation in body size: wasted time, wasted effort?. Comp. Biochem. Physiol. A 122 (1999) 37-44
33. Perry S.F., and Bernier N.J. The acute humoral adrenergic stress response in fish: facts and fiction. Aquaculture 177 (1999) 285-295
34. Pomeranz B., Macaulay R.J.B., Caudill M.A., Kutz I., Adam D., Gordon D., Kilborn K.M., Barger A.C., Shannon D.C., Cohen R.J., and Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am. J. Physiol. 248 (1985) H151-153
35. Reid S.D., Moon T.W., and Perry S.F. Rainbow trout hepatocyte β-adrenoreceptors, catecholamine responsiveness and effects of cortisol. Am. J. Physiol. 262 (1992) R794-799
36. Ruffolo R.R., Bondinell W., and Hieble J.P. α and β-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications. J. Med. Chem. 38 (1995) 3681-3716
37. Strosberg A.D. Structure and function of the beta-3 adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 421-450
38. Sumpter J.P. Environmental effects of human pharmaceuticals. Drug Inform. J. 41 (2007) 143-147
39. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 11 (1998) 3245-3260
40. Ternes T.A., Stuber J., Herrmann N., McDowell D., Ried A., Kampmann M., and Teiser B. Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?. Water Res. 37 (2003) 1976-1982
41. Thorpe K.L., Cummings R.I., Hutchinson T.H., Scholze M., Brighty G., Sumpter J.P., and Tyler C.R. Relative potencies and combination effects of steroidal estrogens in fish. Environ. Sci. Technol. 35 (2003) 1142-1149
42. Walle T., Walle U.K., and Olanoff L.S. Quantitive account of propranolol metabolism in urine of normal man. Drug Metab. Dispos. 13 (1985) 204-209
43. Weber J.-M., and Shanghavi D.S. Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes. Am. J. Physiol. 278 (2000) R956-963
44. Zon L.I., and Peterson R.T. In vivo drug discovery in the Zebrafish. Nat. Drug Discovery 4 (2005) 35-44